Iatrogenic Botulism: A Case Treated With Botulinum Antitoxin.

Clinical neuropharmacology 2023 Vol.46(2) p. 82-84

Gonul Oner O, Gudek HC, Erturk Cetin O, Demir S

관련 도메인

Abstract

[OBJECTIVE] Botulinum toxin type A is widely used for the treatment of spasticity, focal dystonia, hemifacial spasm, hyperhidrosis, strabismus, chronic migraine, and also cosmetic purposes. Therapeutic use is commonly effective and safe. However, if toxin enters the vascular space and gets through to peripheral cholinergic nerve terminals, it may lead to iatrogenic botulism.

[METHOD] We presented a patient who is diagnosed as iatrogenic botulism and treated with antitoxin at the 15th day of the exposure.

[RESULTS] After the antitoxin administration, dramatical response to the treatment was observed.

[CONCLUSIONS] In this report, we want to evaluate a new case of iatrogenic botulism and emphasize the importance of antitoxin administration regardless the timing of the exposure for patients with progressing paralysis.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1

MeSH Terms

Humans; Antitoxins; Botulinum Antitoxin; Botulinum Toxins, Type A; Botulism; Iatrogenic Disease

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문